Advanced Cardiac Life Support (ACLS) Certification and Recertification at WISER using the Laredal Heart Code System.

The Heart Code ACLS course is designed for those individuals that are interested in self paced, PC Driven ACLS certification and recertification. Providers are presented with realistic patient cases and are required to interact with the program to assess the patient, formulate a treatment plan based on the ACLS algorithms and administer treatment.

Considerations:

• This is a self-paced, self-driven certification and recertification program
  
  
• This is an instructorless program There are two parts to the program:
  
  • Part I: The didactic portion requires the participants to complete the computer based scenarios and written exam, we recommend completing this portion at home. This takes an estimated 4-5 hours to complete, but could take longer. Please print the certificate at the end of Part I and bring it to WISER for Part II.
    
    
  •  Part II: The skills portion is done independently utilizing a computer and a sensored manikin at WISER. An estimated 1 hour should be allotted to complete this portion.
    
    
  • Contact WISER at 412-648-6073 to schedule an appointment to complete the skills component. Appointments will be scheduled Monday through Friday 8:00am to 3:00pm. The printed certificate MUST be brought to WISER to complete Part II.

Cost:

• Course fee: $300
  
  

DISCLAIMER STATEMENT

The information presented at this CME program represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.